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It has been almost two years since PLoS
Neglected Tropical Diseases was launched as
the first open-access journal devoted to the
neglected tropical diseases (NTDs). At that
time we aspired to achieve multiple goals
by creating a new journal for the NTD
community. We believed that through an
open-access format, we would provide an
immediate and vital mechanism by which
the community of NTD scientists, public
health experts, and health care profession-
als would have access to the latest
information about these conditions. Back
in 2007, we were especially excited about
reaching investigators in the disease-en-
demic countries, particularly those who
often cannot afford the expense of some of
the more traditional and established bio-
medical journals. To help realize these
goals we went to great lengths to secure a
high level of editorial board representation
from disease-endemic countries in Latin
America, Africa, and Asia. We also hoped
that through our frontmatter articles that
included viewpoints, commentaries, re-
views, and editorials, PLoS Neglected Tropical
Diseases would have an important role in
advocacy and elevating the profile of the
NTDs.
Based on a number of metrics that we
have been following, it is clear that our
community journal is moving in the right
direction and in some cases has already
achieved some of its goals. Article submis-
sions to the journal have been steadily
increasing from throughout the world,
with roughly one-half from ‘‘the North,’’
i.e., the United States, Canada, and
Europe (and also Australia), and the other
half from ‘‘the South,’’ i.e. Latin America
and the Caribbean, Africa, and Asia.
Among the countries in the North we
anticipated receiving a large number of
article submissions from the United States
and the United Kingdom, and indeed this
has been the case. But we were pleasantly
surprised to observe that France is tied
with the United Kingdom for the third
largest number of article submissions. We
have also received a large number of
article submissions from Switzerland, Aus-
tralia, Germany, Belgium, Canada, The
Netherlands, Sweden, and Spain. In the
coming year we hope to see an increase in
submissions from Japan and the Republic
of Korea, where we know there is a
tremendous amount of high-quality scien-
tific activity on the NTDs.
The observation that almost one-half of
our article submissions come from the
NTD-endemic countries is especially grat-
ifying. Brazil now accounts for the second
largest number of article submissions,
behind the United States. Submissions
from Brazil have been extremely high in
quality and cover a wide range of topics,
from molecular pathogenesis and clinical
aspects to epidemiology and policy. There
is also wide representation from a diversity
of research institutes (including FIO-
CRUZ, the Oswaldo Cruz Foundation)
and universities. One of us recently had
the opportunity to attend Med Trop 2009
(the annual Brazilian Congress of Tropical
Medicine, held this year in Recife) in order
to thank the community there for their
support and interest. We are also excited
by the large number of article submissions
from elsewhere in Latin America, includ-
ing Peru, Mexico, and Argentina.
We continue to receive a large number
of article submissions from sub-Saharan
Africa, especially from Kenya, Uganda,
Tanzania, Ethiopia,Co ˆte d’Ivoire, Burkina
Faso, Cameroon, Ghana, Sudan, and
Niger. Because of the enormous disease
burden in Africa and the importance of
building capacity there, we want to con-
tinue to promote scientific activities in this
region and encourage submissions. There-
fore we look forward to continue hearing
from you in this regard. The number of
submissions from Nigeria and South Africa
is much lower than we had hoped for,
given the high quality of scientific activities
that we understand are in place in these
countries. Clearly this is something we
must work on in the coming months. We
hope to receive more papers from the
Middle East—including both Israel and
Iran. The large number of article submis-
sions from Asia—specifically India and
China—is gratifying, but we are striving
to increase submissions to a level similar to
that from Brazil. Submissions from Ban-
gladesh and Pakistan need to increase, as
well as those from Southeast Asia, espe-
cially Indonesia. We are pleased about the
large number of articles that we receive
from Thailand, Vietnam, and Lao DR.
In addition to the quantity of papers,
the quality of papers published in PLoS
Neglected Tropical Diseases has remained
high. A relatively small percentage of all
submitted articles are accepted for publi-
cation, and we believe that this high
quality is reflected in our first impact
factor of 4.2 (based on the last nine weeks
of 2007 after the journal was first
launched), which positions the journal as
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Both the print and electronic media have
been unusually receptive to reporting on
scientific results published in PLoS Neglected
Tropical Diseases. Information about our
scientific findings and frontmatter pieces
has appeared frequently and regularly in
general scientific and medical journals
such as Science, Nature, and The Lancet,a s
well as high-profile lay publications such as
the New York Times, Los Angeles Times,
Reuters, AP, USA Today, Wall Street Journal,
Financial Times, and The Economist, among
others. We are grateful to the journalists
who cover NTDs for these publications, as
they provide an important role in not only
informing readers about these conditions,
but also serving to elevate the profile of
these diseases. We feel that this intensive
media coverage has also provided an
important advocacy role in getting NTDs
onto the agendas of a number of interna-
tional agencies, such as the United Na-
tions, the World Health Organization, and
the governments representing the Group
of Eight (G8) countries, including some
nations that have provided substantial
donor support. We are also very grateful
to the Bill & Melinda Gates Foundation
for providing early seed funding for
launching our journal.
Most of the NTDs have been well
represented in PLoS Neglected Tropical Dis-
eases during its first two years, including, of
course, helminth and protozoan infections,
but also many bacterial and viral (espe-
cially arboviral) infections. The numerous
submissions we have received on bacterial
and viral NTDs (and their vectors) has
motivated us to expand our editorial board
in order to add expertise on these
conditions. Indeed, the overwhelming
response from the NTD community with
respect to the number and quality of
article submissions has prompted us to
revisit how we accommodate and manage
growth. We are therefore pleased to
announce that former Deputy Editor
Serap Aksoy from Yale University has
joined Peter Hotez as Editor-in-Chief of
the journal. Serap is a leading authority on
the vector biology of human African
trypanosomiasis, but she also has wide-
ranging interests on all aspects of micro-
bial pathogens and their vectors. She has
been instrumental in capacity-building for
research in endemic countries. Currently
she either manages or assists training
programs in China, Colombia, Turkey,
Uganda, and Kenya in the area of vector
borne disease control. She also chairs the
WHO/TDR committee on Innovative
Vector Control. In 2008 in Kampala,
Uganda, Serap led an interactive (and
highly attended) writing workshop on
behalf of PLoS Neglected Tropical Diseases.
Serap grew up in Turkey and completed
her education in the United States at
Vassar College and then Columbia Uni-
versity. We have known each other for
more than 20 years, having first worked
closely together as postdoctoral fellows in
the laboratory of Professor Frank Richards
at Yale University. Together with the
outstanding editorial staff at PLoS, we
look forward to jointly promoting journal
activities and outreach and working closely
with the Editorial Board. These last two
years have been exciting ones for not only
PLoS Neglected Tropical Diseases, but indeed
for the entire NTD community, and we
look forward to hearing from you in the
coming weeks and months.
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